Podiatrists in Lake Ronkonkoma, NY Accepting Medicare
3 Podiatrists found. Showing 1 - 3
 Dr. Myles Savitt, DPM Podiatrist - Foot Surgery Medicare: Not Enrolled in Medicare Practice Location: 388 Hawkins Ave, Lake Ronkonkoma, NY 11779 Phone: 631-585-0045 Fax: 631-585-7860 |
Dr. George Daniel Emmons, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 388 Hawkins Ave, Lake Ronkonkoma, NY 11779 Phone: 631-585-0045 Fax: 631-585-7860 |
 Ronkonkoma Podiatry Center Podiatrist Medicare: Medicare Enrolled Practice Location: 388 Hawkins Ave, Lake Ronkonkoma, NY 11779 Phone: 631-585-0045 Fax: 631-585-7860 |
News Archive
College students more likely to talk about sexual health issues after watching TV shows
"What would Samantha and Miranda do?" That's what viewers of the past HBO series Sex and the City may ask themselves when faced with the prospect of uncomfortable discussions about sexual health with partners, friends and doctors.
Study: Just and socially responsible layoff process is important for emotional health of workers
Researchers led by a University of North Texas Health Science Center epidemiologist found that a just and socially responsible layoff process is important for the emotional health of workers – a study that occurred during the most severe recession since the Great Depression.
NanoViricides to apply 'lead optimization technology' to anti-HIV candidate
NanoViricides, Inc. recently reported on its completed animal study that compared its lead anti-HIV candidate HIVCide™, to a HAART (highly active anti retroviral therapy) triple drug cocktail. The cocktail used therein is based on an anti-HIV therapeutic protocol in current practice. The Company has received numerous inquiries for simplified explanation of the results.
Vitamin D blood test may have potential to rapidly diagnose bipolar disorder in children
A blood test may have the potential to speed accurate diagnosis - and proper treatment - of bipolar disorder in children, new research suggests.
CASI Pharmaceuticals announces net loss of $21.5M in third quarter 2014
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China, today reported financial results for the three and nine months ended September 30, 2014.
› Verified 4 days ago
Speech-Language Pathologists
Physical Therapists
Optometrists
Chiropractors
Podiatrists
Occupational Therapists